A quinazoline derivative which is an alpha-1-selective adrenoceptor blocking agent used on once-a-day basis for therapy of mild-to-moderate hypertension. Terazosin is indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH). Reference standards of Terazosin API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
1-[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-5-hydroxy-1-pentanone-d8
Catalogue No.:PA STI 088226
CAS :
Molecular Formula : C19H19D8N5O4
Molecular Weight : 397.50
[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl][(5S)-tetrahydro-5-methyl-2-furanyl]methanone-d8
Catalogue No.:PA STI 088227
Molecular Formula : C20H19D8N5O4
Molecular Weight : 409.51
1-(4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl-2,2,3,3,5,5,6,6-d8)-2-hydroxypentan-1-one
Catalogue No.:PA STI 088228
(4-(4-Amino-6-hydroxy-7-methoxyquinazolin-2-yl)piperazin-1-yl-2,2,3,3,5,5,6,6-d8)(tetrahydrofuran-2-yl)methanone
Catalogue No.:PA STI 088229
Molecular Formula : C18H15D8N5O4
Molecular Weight : 381.46
(4-(4-Amino-7-hydroxy-6-methoxyquinazolin-2-yl)piperazin-1-yl-2,2,3,3,5,5,6,6-d8)(tetrahydrofuran-2-yl)methanone
Catalogue No.:PA STI 088230
Catalogue No.:PA IPIMP 005 13
Molecular Formula :
Molecular Weight : NA
Catalogue No.:PA IPIMP 006 13
Catalogue No.:PA IPIPRS 130 12
Terazosin hydrochloride dihydrate (Y0000621)
Catalogue No.:PA EPY0000621
Molecular Formula : NA
Terazosin impurity N (Y0000624)
Catalogue No.:PA EPY0000624
Terazosin impurity E (Y0000665)
Catalogue No.:PA EPY0000665
Catalogue No.:PA USP1643452
Catalogue No.:PA USP1643463
Catalogue No.:PA USP1643474
Catalogue No.:PA USP1643485
Catalogue No.:PA STI 088231
Molecular Formula : C19H17D8N5O4
Molecular Weight : 395.49
4-Amino-6,7-dimethoxyquinazolin-2(1H)-one Hydrochloride
Catalogue No.:PA 20 0111001
Molecular Formula : C10H12ClN3O3
Molecular Weight : 257.67
Terazosin
Catalogue No.:PA 20 3060000
Molecular Formula : C19H25N5O4
Molecular Weight : 387.44
2-Hydroxy-1-(piperazin-1-yl)pentan-1-one
Catalogue No.:PAI 20 306002
Molecular Formula : C9H18N2O2
Molecular Weight : 186.26
Tert-butyl 4-(2-hydroxypentanoyl)piperazine-1-carboxylate
Catalogue No.:PAI 20 306001
Molecular Formula : C14H26N2O4
Molecular Weight : 286.37
N'-Methyl-N,N-diphenylurea
Catalogue No.:PA 20 0111000
Molecular Formula : C14H14N2O
Molecular Weight : 226.28
2-Hydroxypentanoyl Chloride
Catalogue No.:PAI 20 306003
Molecular Formula : C5H9ClO2
Molecular Weight : 136.58
(4-Nitrosopiperazin-1-yl)(tetrahydrofuran-2-yl)methanone
Catalogue No.:PA 20 3061000
Molecular Formula : C9H15N3O3
Molecular Weight : 213.24
Terazosin for system suitability A (Y0002286)
Catalogue No.:PA EPY0002286
(4-Nitrosopiperazin-1-yl-2,2,3,3,5,5,6,6-d8)(tetrahydrofuran-2-yl)methanone
Catalogue No.:PA STI 089737
Molecular Formula : C9H7D8N3O3
Molecular Weight : 221.29
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
